25
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Effects of Contingent Payment on Compliance with a Naltrexone Regimen

, , , , &
Pages 355-365 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Stacey C. Sigmon, Adam Bisaga, Edward V. Nunes, Patrick G. O'Connor, Thomas Kosten & George Woody. (2012) Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice. The American Journal of Drug and Alcohol Abuse 38:3, pages 187-199.
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Kathleen M. Carroll & Bruce J. Rounsaville. (2007) A Perfect Platform: Combining Contingency Management with Medications for Drug Abuse. The American Journal of Drug and Alcohol Abuse 33:3, pages 343-365.
Read now
Maria A. Sullivan, Jami L. Rothenberg, Suzanne K. Vosburg, Sarah H. Church, Shara J. Feldman, Eva M. Epstein, Herbert D. Kleber & Edward V. Nunes. (2006) Predictors of Retention in Naltrexone Maintenance for Opioid Dependence: Analysis of a Stage I Trial. American Journal on Addictions 15:2, pages 150-159.
Read now
Gantt Galloway & Gregory Hayner. (1993) Haight-Ashbury Free Clinics' Drug Detoxification Protocols — Part 2: Opioid Blockade. Journal of Psychoactive Drugs 25:3, pages 251-252.
Read now
John Grabowski & Steven I. Dworkin. (1985) Cocaine: An Overview of Current Issues. International Journal of the Addictions 20:6-7, pages 1065-1088.
Read now
Thomas R. Kosten & Herbert D. Kleber. (1984) Strategies to Improve Compliance with Narcotic Antagonists. The American Journal of Drug and Alcohol Abuse 10:2, pages 249-266.
Read now
Robert A. Greenstein, Charles P. O'Brien, A. Thomas McLellan, George E. Woody, John Grabowski, Melody Long, Geraldine Coyle-Perkins & Anita Vittor. (1981) Naltrexone: A Short-Term Treatment for Opiate Dependence. The American Journal of Drug and Alcohol Abuse 8:3, pages 291-300.
Read now

Articles from other publishers (22)

Peter D. Friedmann, Kelly E. Dunn, Edward V. Nunes & Charles P. O’Brien. (2018) Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT. Journal of Substance Abuse Treatment 85, pages 31-33.
Crossref
Kathleen M. Carroll. (2014) Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice. Annals of the New York Academy of Sciences, pages n/a-n/a.
Crossref
Anthony DeFulio & Kenneth Silverman. (2012) The use of incentives to reinforce medication adherence. Preventive Medicine 55, pages S86-S94.
Crossref
Nancy M. Petry, Carla J. Rash, Shannon Byrne, Shehryar Ashraf & William B. White. (2012) Financial Reinforcers for Improving Medication Adherence: Findings from a Meta-analysis. The American Journal of Medicine 125:9, pages 888-896.
Crossref
Jeffrey J. Everly, Anthony DeFulio, Mikhail N. Koffarnus, Jeannie‐Marie S. Leoutsakos, Wendy D. Donlin, Will M. Aklin, Annie Umbricht, Michael Fingerhood, George E. Bigelow & Kenneth Silverman. (2011) Employment‐based reinforcement of adherence to depot naltrexone in unemployed opioid‐dependent adults: a randomized controlled trial. Addiction 106:7, pages 1309-1318.
Crossref
Timothy B. Baker, Robin Mermelstein, Linda M. Collins, Megan E. Piper, Douglas E. Jorenby, Stevens S. Smith, Bruce A. Christiansen, Tanya R. Schlam, Jessica W. Cook & Michael C. Fiore. (2010) New Methods for Tobacco Dependence Treatment Research. Annals of Behavioral Medicine 41:2, pages 192-207.
Crossref
Evgeny M Krupitsky, Edwin E Zvartau, Dimitry V Masalov, Marina V Tsoi, Andrey M Burakov, Valentina Y Egorova, Tatyana Y Didenko, Tatyana N Romanova, Eva B Ivanova, Anton Y Bespalov, Elena V Verbitskaya, Nikolai G Neznanov, Alexandr Y Grinenko, Charles P O'Brien & George E Woody. (2004) Naltrexone for heroin dependence treatment in St. Petersburg, Russia. Journal of Substance Abuse Treatment 26:4, pages 285-294.
Crossref
John Grabowski, Howard Rhoades, Angela Stotts, Katherine Cowan, Charles Kopecky, Anne Dougherty, F Gerard Moeller, Sohela Hassan & Joy Schmitz. (2003) Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials. Neuropsychopharmacology 29:5, pages 969-981.
Crossref
Jami L Rothenberg, Maria A Sullivan, Sarah H Church, Angela Seracini, Eric Collins, Herbert D Kleber & Edward V Nunes. (2002) Behavioral naltrexone therapy. Journal of Substance Abuse Treatment 23:4, pages 351-360.
Crossref
Vania Modesto-Lowe & Jeffrey Van Kirk. (2002) Clinical uses of naltrexone: A review of the evidence.. Experimental and Clinical Psychopharmacology 10:3, pages 213-227.
Crossref
RICHARD A. RAWSON, MICHAEL J. MCCANN, STEVEN J. SHOPTAW, KAREN A. MIOTTO, DOMINICK L. FROSCH, JEANNE L. OBERT & WALTER LING. (2009) Naltrexone for opioid dependence: evaluation of a manualized psychosocial protocol to enhance treatment response. Drug and Alcohol Review 20:1, pages 67-78.
Crossref
Nancy M. Petry. (2000) A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence 58:1-2, pages 9-25.
Crossref
Kenzie L. Preston, Kenneth Silverman, Annie Umbricht, Anna DeJesus, Ivan D. Montoya & Charles R. Schuster. (1999) Improvement in naltrexone treatment compliance with contingency management. Drug and Alcohol Dependence 54:2, pages 127-135.
Crossref
Kathleen M. Carroll. 1998. Treating Addictive Behaviors. Treating Addictive Behaviors 217 229 .
Conor K Farren. (2014) The use of naltrexone, an opiate antagonist, in the treatment of opiate addiction. Irish Journal of Psychological Medicine 14:1, pages 31-34.
Crossref
Kathleen M. Carroll. (1997) Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. Addictive Behaviors 22:2, pages 233-245.
Crossref
Augusta Roth, Izola Hogan & Conor Farren. (1997) Naltrexone plus group therapy for the treatment of opiate-abusing health-care professionals. Journal of Substance Abuse Treatment 14:1, pages 19-22.
Crossref
Stephanie S. O'Malley & Kathleen M. Carroll. (1996) Psychotherapeutic Considerations in Pharmacological Trials. Alcoholism: Clinical and Experimental Research 20:s7, pages 17A-22A.
Crossref
Leslie Amass, Warren K. Bickel, John P. Crean, Stephen T. Higgins & Gary J. Badger. (1996) Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program. Journal of Substance Abuse Treatment 13:1, pages 43-49.
Crossref
Ronith Elk, Joy Schmitz, Ralph Spiga, Howard Rhoades, Robert Andres & John Grabowski. (1995) Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addictive Behaviors 20:4, pages 533-542.
Crossref
Charles P. O’Brien & George E. Woody. 1986. Research Advances in Alcohol and Drug Problems. Research Advances in Alcohol and Drug Problems 245 260 .
Robert A. Greenstein, Bradley D. Evans, A.Thomas Mclellan & Charles P. O'Brien. (1983) Predictors of favorable outcome following naltrexone treatment. Drug and Alcohol Dependence 12:2, pages 173-180.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.